Cause of death, by non-communicable diseases, ages 15-59 in Low & middle income
Low & middle income: Cause of death, by non-communicable diseases, ages 15-59 was 51.2% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 15-59 in Low & middle income, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 15-59.
Analysis
Low & middle income recorded 51.2% for cause of death, by non-communicable diseases, ages 15-59 in 2021.
That represents a change of down 10.4% on the previous year and down 5.0% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59 in Low & middle income peaked at 61.2% in 2019 and was at its lowest, 47.7%, in 2000.
That places Low & middle income 22nd out of 47 groups with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59 in Low & middle income, year by year
| Year | % of total deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 47.7% | — |
| 2010 | 53.9% | +12.9% |
| 2015 | 58.2% | +8.1% |
| 2019 | 61.2% | +5.0% |
| 2020 | 57.1% | -6.6% |
| 2021 | 51.2% | -10.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 47.7% | 47.7% | 47.7% | 1 |
| 2010s | 57.8% | 53.9% | 61.2% | 3 |
| 2020s | 54.2% | 51.2% | 57.1% | 2 |
Countries ranked near Low & middle income
- 19 France 76.3% compare
- 20 Australia 76.3% compare
- 21 Micronesia (country) 75.6% compare
- 22 Norway 75.6% compare
- 23 Switzerland 75.1% compare
- 24 Austria 74.9% compare
- 25 Luxembourg 74.8% compare
More health data for Low & middle income
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 1.41 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0331 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, annual growth rate -0.9493 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 2.33 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0323 units per person (2025)
- Population ages 35-39, female, per capita 0.036 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59 in Low & middle income?
- Cause of death, by non-communicable diseases, ages 15-59 in Low & middle income was 51.2% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59 recorded in Low & middle income?
- The highest recorded value was 61.2% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59 recorded in Low & middle income?
- The lowest recorded value was 47.7% in 2000.
- How does Low & middle income rank for cause of death, by non-communicable diseases, ages 15-59?
- Low & middle income ranks 22nd out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59 rising or falling in Low & middle income?
- Over the last ten years it is down 5.0%. The long-run trend across the full record is rising.
- Where does this Low & middle income data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.